A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma

[1]  S. Pastorino,et al.  Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma , 2015, Oncotarget.

[2]  M. Haigis,et al.  Mitochondria and Cancer , 2016, Cell.

[3]  Jae-Seon Lee,et al.  Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis , 2016, Oncotarget.

[4]  T. Chung,et al.  New p32/gC1qR Ligands for Targeted Tumor Drug Delivery , 2016, Chembiochem : a European journal of chemical biology.

[5]  F. Sotgia,et al.  High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant , 2015, Oncotarget.

[6]  Jin Han,et al.  Mitochondria as therapeutic targets for cancer stem cells. , 2015, World journal of stem cells.

[7]  S. Pastorino,et al.  Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction , 2014, Oncotarget.

[8]  J. Wang,et al.  Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer , 2015, Tumor Biology.

[9]  E. Cheng,et al.  Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. , 2014, Molecular cell.

[10]  E. Peerschke,et al.  cC1qR/CR and gC1qR/p33: observations in cancer. , 2014, Molecular immunology.

[11]  E. Ruoslahti,et al.  Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  J. Wang,et al.  Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients. , 2013, Experimental and molecular pathology.

[13]  Peng Huang,et al.  Targeting cancer cell mitochondria as a therapeutic approach. , 2013, Future medicinal chemistry.

[14]  T. Uchiumi,et al.  p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability , 2012, Nucleic acids research.

[15]  C. Baines,et al.  The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death , 2011, Cell cycle.

[16]  P. Mischel,et al.  Metabolic state of glioma stem cells and nontumorigenic cells , 2011, Proceedings of the National Academy of Sciences.

[17]  Yoon Ki Kim,et al.  Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis*♦ , 2011, Journal of Biological Chemistry.

[18]  K. Kuroiwa,et al.  Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate‐specific antigen relapse time after radical prostatectomy , 2011, Cancer science.

[19]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[20]  E. Ruoslahti,et al.  The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies* , 2010, The Journal of Biological Chemistry.

[21]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[22]  L. Galluzzi,et al.  Targeting mitochondria for cancer therapy , 2010, Nature Reviews Drug Discovery.

[23]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[24]  Feng Yang,et al.  LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. , 2010, International journal of pharmaceutics.

[25]  Jeffrey W. Smith,et al.  Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation , 2010, Molecular and Cellular Biology.

[26]  C. Dang.  p32 (C1QBP) and Cancer Cell Metabolism: Is the Warburg Effect a Lot of Hot Air? , 2010, Molecular and Cellular Biology.

[27]  D. Pang,et al.  Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer , 2009, Journal of surgical oncology.

[28]  Jae-Seon Lee,et al.  Proteome analysis of adipocyte lipid rafts reveals that gC1qR plays essential roles in adipogenesis and insulin signal transduction , 2009, Proteomics.

[29]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[30]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[31]  Erkki Ruoslahti,et al.  Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. , 2008, Cancer research.

[32]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[33]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[34]  R. Ashfaq,et al.  Receptor for the globular heads of C1q (gC1q‐R, p33, hyaluronan‐binding protein) is preferentially expressed by adenocarcinoma cells , 2004, International journal of cancer.

[35]  E. Ruoslahti,et al.  Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Peerschke,et al.  gC1q‐R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection , 2001, Immunological reviews.

[37]  A. Krainer,et al.  Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Kang,et al.  p32 Protein, a Splicing Factor 2-associated Protein, Is Localized in Mitochondrial Matrix and Is Functionally Important in Maintaining Oxidative Phosphorylation* , 1997, The Journal of Biological Chemistry.

[39]  K. Preissner,et al.  The Binding Protein for Globular Heads of Complement C1q, gC1qR , 1996, The Journal of Biological Chemistry.

[40]  A. Willis,et al.  Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q , 1994, The Journal of experimental medicine.